Listar por autor "Zachou, K."
Mostrando ítems 1-20 de 87
-
Alpha-actinin: A multidisciplinary protein with important role in B-cell driven autoimmunity
Kikonomou, K. G.; Zachou, K.; Dalekos, G. N. (2011)Alpha-actinin (α-actinin) is a ubiquitous cytoskeletal protein, which belongs to the superfamily of filamentous actin (F-actin) crosslinking proteins. It is present in multiple subcellular regions of both muscle and ... -
Alterations of leptin during IFN-alpha therapy in patients with chronic viral hepatitis
Zografos, T. A.; Rigopoulou, E. I.; Liaskos, C.; Togousidis, E.; Zachou, K.; Gatselis, N.; Germenis, A.; Dalekos, G. N. (2006)Background/Aims: Leptin has a particular profibrogenic role in the liver. We investigated whether IFN-alpha influences leptin production in patients with chronic hepatitis B (CHB) and C (CHC). Leptin was determined in ... -
Anti-a actinin antibodies as new predictors of response to treatment in autoimmune hepatitis type 1
Zachou, K.; Oikonomou, K.; Renaudineau, Y.; Chauveau, A.; Gatselis, N.; Youinou, P.; Dalekos, G. N. (2012)Background We reported that combined presence of autoantibodies (Abs) against filamentous-actin (AFA) and a-actinin are specific for autoimmune hepatitis type 1 (AIH-1) diagnosis. Aim To explore our data and assess whether ... -
ANTI-alpha ACTININ ANTIBODIES ARE INDEPENDENT PREDICTORS OF RESPONSE TO TREATMENT IN AUTOIMMUNE HEPATITIS TYPE 1
Zachou, K.; Renaudineau, Y.; Chauveau, A.; Youinou, P.; Dalekos, G. N. (2010) -
Anti-alpha-actinin antibodies cross-react with Anti-ssDNA antibodies in active autoimmune hepatitis
Renaudineau, Y.; Dalekos, G. N.; Gueguen, P.; Zachou, K.; Youinou, P. (2008)Recently, we have observed that the association of anti-F-actin autoantibodies (Abs) with anti-alpha-actinin Abs (double reactivity) was correlated with liver disease activity in autoimmune hepatitis type 1 (AIH-1; Gueguen ... -
Anti-cardiolipin antibodies (anti-CL) in patients with hepatitis C virus (HCV) infection are independent of beta2-glycoprotein I (b2GPI) co-factor or features of antiphospholipid syndrome (APS)
Zachou, K.; Liaskos, C.; Christodoulou, D.; Kardasi, M.; Papadamou, G.; Gatselis, N.; Gerovasilis, F.; Tsianos, E.; Dalekos, G. (2002) -
Anti-cardiolipin antibodies in patients with chronic viral hepatitis are independent of beta2-glycoprotein I cofactor or features of antiphospholipid syndrome
Zachou, K.; Liaskos, C.; Christodoulou, D. K.; Kardasi, M.; Papadamou, G.; Gatselis, N.; Georgiadou, S. P.; Tsianos, E. V.; Dalekos, G. N. (2003)Background Although controversial, some authorities have implicated hepatitis C virus (HCV) as a cause of anti-phospholipid syndrome (APLS). Anti-cardiolipin antibodies (anti-CLAbs) in APLS are cofactor-dependent ('pathogenic' ... -
Anti-HDV immunoglobulin M testing in hepatitis delta revisited: correlations with disease activity and response to pegylated interferon-alpha 2a treatment
Mederacke, I.; Yurdaydin, C.; Dalekos, G. N.; Bremer, B.; Erhardt, A.; Cakaloglu, Y.; Yalcin, K.; Gurel, S.; Zeuzem, S.; Zachou, K.; Bozkaya, H.; Dienes, H. P.; Manns, M. P.; Wedemeyer, H.; Hep-Net Int Delta Hepatitis, Study (2012)Background: The role of anti-HDV immunoglobulin M (IgM) testing in patients receiving pegylated interferon-alpha therapy for hepatitis delta is unknown. We performed anti-HDV IgM testing in a well defined cohort of HDVinfected ... -
ANTI-HDV-IGM TESTING IN HEPATITIS DELTA REVISITED: CORRELATIONS WITH DISEASE ACTIVITY AND RESPONSE TO PEGYLATED INTERFERON ALFA-2A TREATMENT
Mederacke, I.; Yurdaydin, C.; Bremer, B.; Cakaloglu, Y.; Erhardt, A.; Yalcin, K.; Zachou, K.; Gurel, S.; Heidrich, B.; Dalekos, G.; Dienes, H. P.; Manns, M. P.; Wedemeyer, H. (2010) -
Anti-SLA/LP alone or in combination with anti-Ro52 and fine specificity of anti-Ro52 antibodies in patients with autoimmune hepatitis
Zachou, K.; Gampeta, S.; Gatselis, N. K.; Oikonomou, K.; Goulis, J.; Manoussakis, M. N.; Renaudineau, Y.; Bogdanos, D. P.; Dalekos, G. N. (2015)Background & AimsAntibodies (Abs) to soluble liver antigen/liver pancreas (anti-SLA/LP) are considered markers of worse prognosis and outcome in patients with autoimmune hepatitis (AIH) although this assumption has recently ... -
The antiphospholipid syndrome and infection
Dalekos, G. N.; Zachou, K.; Liaskos, C. (2001)Infectious agents have been implicated in the induction of antiphospholipid (aPL) antibodies and the development of the antiphospholipid syndrome (APS). This review focuses on the types of aPL antibodies detected in ... -
Autoantibodies and autoantigens in autoimmune hepatitis: Important tools in clinical practice and to study pathogenesis of the disease
Zachou, K.; Rigopoulou, E.; Dalekos, G. N. (2004)Autoimmune hepatitis (AIH) is a chronic necroinflammatory disease of the liver characterized by hypergammaglobulinemia, characteristic autoantibodies, association with HLA DR3 or DR4 and a favorable response to immunosuppressive ... -
Autoimmune hepatitis in patients with chronic HBV and HCV infections: Patterns of clinical characteristics, disease progression and outcome
Rigopoulou, E. I.; Zachou, K.; Gatselis, N.; Koukoulis, G. K.; Dalekos, G. N. (2014)We retrospectively investigated the characteristics, patterns of disease progression, outcome and difficulties in the management in 11 patients with concurrent autoimmune hepatitis (AIH) and HBV or HCV infections (5 HCV ... -
Autoimmune hepatitis natural history: a single Greek center experience focused on long-term effect of mycophenolate mofetil as first line treatment
Zachou, K.; Gatselis, N.; Gabeta, S.; Saitis, A. I.; Papadamou, G.; Rigopoulou, E. I.; Koukoulis, G. K.; Dalekos, G. N. (2013) -
Autoimmune hepatitis type 1 and primary biliary cirrhosis have distinct bone marrow cytokine production
Zachou, K.; Rigopoulou, E. I.; Tsikrikoni, A.; Alexandrakis, M. G.; Passam, F.; Kyriakou, D. S.; Stathakis, N. E.; Dalekos, G. N. (2005)We have recently reported differences in the hematopoiesis between autoimmune hepatitis type I (AIH-1) and primary biliary cirrhosis (PBC). In view of the notion that cytokines are regulators of hematopoiesis, we investigated ... -
Autoimmune hepatitis, one disease with many faces: Etiopathogenetic, clinico-laboratory and histological characteristics
Gatselis, N. K.; Zachou, K.; Koukoulis, G. K.; Dalekos, G. N. (2015)Autoimmune hepatitis (AIH) is an unresolving progressive liver disease of unknown etiology characterized by hypergammaglobulinemia, autoantibodies detection and interface hepatitis. Due to the absence of specific diagnostic ... -
Bone marrow findings in patients with autoimmune liver diseases
Tsikrikoni, A.; Rigopoulou, E. I.; Zachou, K.; Liaskos, C.; Kyriakou, D.; Dalekos, G. N. (2008)Background and Aims: We have recently reported quantitative and qualitative differences of the bone marrow (BM) hematopoietic progenitor cells in autoimmune hepatitis type-1 (AIH-1) and primary biliary cirrhosis (PBC). In ... -
Cartilage oligomeric matrix protein (COMP) serum levels: a new non-invasive biomarker of liver fibrosis in patients with chronic viral hepatitis
Gabeta, S.; Zachou, K.; Shums, Z.; Gatselis, N.; Koukoulis, G. K.; Norman, G. L.; Dalekos, G. N. (2014) -
A case of membranous nephropathy associated with Sjogren syndrome, polymyositis and autoimmune hepatitis
Stefanidis, I.; Giannopoulou, M.; Liakopoulos, V.; Dovas, S.; Karasavvidou, F.; Zachou, K.; Koukoulis, G. K.; Dalekos, G. N. (2008)Sjogren syndrome (SS) is a chronic systemic autoimmune disease characterized by lymphocylic infiltration of exocrine glands, especially lacrimal and salivary. The immunologic process which occurs in this syndrome is B cell ... -
A case of membranous nephropathy associated with Sjögren syndrome, polymyositis and autoimmune hepatitis
Stefanidis, I.; Giannopoulou, M.; Liakopoulos, V.; Dovas, S.; Karasavvidou, F.; Zachou, K.; Koukoulis, G. K.; Dalekos, G. N. (2008)Sjögren syndrome (SS) is a chronic systemic autoimmune disease characterized by lymphocytic infiltration of exocrine glands, especially lacrimal and salivary. The immunologic process which occurs in this syndrome is B cell ...